Benzinga | Aug 3, 2020 04:04PM EDT

Neurocrine Biosciences Q2 Adj. EPS $1.42 Beats $0.73 Estimate, Sales $302.40M Beat $260.34M Estimate

Neurocrine Biosciences (NASDAQ:NBIX) reported quarterly earnings of $1.42 per share which beat the analyst consensus estimate of $0.73 by 94.52 percent. This is a 100 percent increase over earnings of $0.71 per share from the same period last year. The company reported quarterly sales of $302.40 million which beat the analyst consensus estimate of $260.34 million by 16.16 percent. This is a 64.72 percent increase over sales of $183.58 million the same period last year.